The Joslin Diabetes Center just received $5 million from the Massachusetts Life Sciences Center and raised another $5.8 million to match by tapping its donor base. These funds will build a Translational Center for the Cure of Diabetes.
Translational research deals with the connection between bench research in a lab (the type of research involving molecules, enzymes and rats) and practical applications for people. Traditionally bench research is done to answer a scientific question without consideration of product marketability.
Joslin expects the Translational Center to foster new research approaches whereby basic, translational and clinical researchers work side-by-side and collaborate with Joslin’s clinical team in an interactive and supportive environment, enabling exciting new ideas to flourish. Here, the latest innovative technologies and new biomedical discoveries can be advanced so that they can be translated quickly into solutions that help patients and others with or at risk of diabetes.
“The Translational Center for the Cure of Diabetes will enable us to accelerate our clinical
and research endeavors,” said George King, M.D., Joslin’s Chief Scientific Officer. “It will ensure we have the most up to date infrastructure, through the creation of new labs and new platforms, that will lead to the development of translational studies for curing Type 1 and Type 2 diabetes, and their complications, as well as advancing our work in diabetes prevention and obesity.“
Joslin has recently added two new departments, Joslin Technologies and the Office of Commercialization which will be working in the Translational Center to help expand Joslin’s business prospects. The combination of the two departments and the center will provide research expertise for businesses working on diabetes products, and will partner with area drug and device companies to bring diabetes innovations to market.
In addition to being a boon for Joslin’s research and clinical teams, the Translational Center will create jobs. The project will renovate nearly 20,000 square feet of space and is projected to create approximately 50 construction jobs beginning in FY13, and approximately 50 new permanent jobs in the life sciences.
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts, created by the Massachusetts legislature in June 2006. It is tasked with investing in life sciences research and economic development. This work includes making financial investments in public and private institutions growing life sciences research, development and commercialization as well as building ties between sectors of the Massachusetts life sciences community.